$6.82
-0.07[-1.02%]
At close: Apr 19
$6.82
0[0.00%]
After Hours: 7:32PM EDT
Altimmune reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Altimmune using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | AM | ALT | Q1 | -$0.40 | -$0.38 | — | — | $21.00K | — | — | — | Get Alert |
03/27/2024 | AM | ALT | Q4 | -$0.43 | -$0.43 | -$0.33 | 23.26% | -$110.00K | — | $37.00K | — | Get Alert |
11/07/2023 | AM | ALT | Q3 | -$0.48 | -$0.42 | -$0.39 | 7.14% | $2.00K | — | $362.00K | — | Get Alert |
08/10/2023 | AM | ALT | Q2 | -$0.42 | -$0.46 | -$0.32 | 30.43% | $8.00K | — | $6.00K | — | Get Alert |
05/11/2023 | AM | ALT | Q1 | -$0.44 | -$0.48 | -$0.40 | 16.67% | $32.00K | — | $21.00K | — | Get Alert |
02/28/2023 | AM | ALT | Q4 | -$0.57 | -$0.50 | -$0.43 | 14.00% | $3.28M | $30.00K | -$110.00K | -466.67% | Get Alert |
11/10/2022 | AM | ALT | Q3 | -$0.81 | -$0.50 | -$0.48 | 4.00% | $200.00K | $870.00K | $2.00K | -99.77% | Get Alert |
08/11/2022 | AM | ALT | Q2 | -$0.41 | -$0.51 | -$0.42 | 17.65% | $137.62K | $870.00K | $8.00K | -99.08% | Get Alert |
05/12/2022 | AM | ALT | Q1 | -$0.38 | -$0.58 | -$0.44 | 24.14% | $837.52K | $1.03M | $32.00K | -96.89% | Get Alert |
03/15/2022 | AM | ALT | Q4 | -$0.17 | -$0.65 | -$0.57 | 12.31% | $2.31M | $90.00K | $3.28M | 3542.22% | Get Alert |
11/09/2021 | PM | ALT | Q3 | -$0.54 | $0.39 | -$0.81 | -307.69% | $2.94M | $60.00K | $200.00K | 233.33% | Get Alert |
08/10/2021 | PM | ALT | Q2 | -$0.94 | -$0.50 | -$0.41 | 18.00% | $721.64K | $1.84M | $137.62K | -92.52% | Get Alert |
05/17/2021 | AM | ALT | Q1 | -$0.26 | -$0.47 | -$0.38 | 19.15% | $2.21M | — | $837.52K | — | Get Alert |
02/25/2021 | AM | ALT | Q4 | -$0.25 | -$0.75 | -$0.17 | 77.33% | $575.80K | $2.14M | $2.31M | 8.08% | Get Alert |
11/09/2020 | PM | ALT | Q3 | -$0.74 | -$0.76 | -$0.54 | 28.95% | $643.98K | $1.05M | $2.94M | 179.81% | Get Alert |
08/11/2020 | PM | ALT | Q2 | -$0.26 | -$0.40 | -$0.94 | -135.00% | $1.63M | $1.10M | $721.64K | -34.40% | Get Alert |
05/13/2020 | AM | ALT | Q1 | -$0.27 | -$0.32 | -$0.26 | 18.75% | $2.96M | $500.00K | $2.21M | 342.60% | Get Alert |
03/27/2020 | AM | ALT | Q4 | -$0.02 | -$0.26 | -$0.25 | 3.85% | $2.59M | $750.00K | $575.80K | -23.23% | Get Alert |
11/13/2019 | PM | ALT | Q3 | -$1.73 | -$0.19 | -$0.74 | -289.47% | $2.63M | $2.63M | $643.98K | -75.51% | Get Alert |
Altimmune (ALT) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 27, 2024 for Q4.
The Actual EPS was $-0.33, which beat the estimate of $-0.43.
The Actual Revenue was $37K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.